Chronic Malignancies Working Party (CMWP)
Study type:
Study number:
42204421
Type of Stem Cell Treatment:
Diseases:
Chronic Lymphocytic Leukaemia (CLL)
Short title:
Primary objective:
Key inclusion criteria:
>18years old, CLL
Country:
Principal investigator:
Johannes Schetelig
EBMT Study coordinator:
Annelies Kleijne